- Nick Fox (n.j.fox@shef.ac.uk), reader in the sociology of health and the body1,
- Katie Ward, research associate1
- 1 School of Health and Related Research, University of Sheffield, Sheffield S1 4DA
- Correspondence to: N Fox
Introduction
The globalisation of production and consumption challenges the ways in which potentially harmful yet essential technologies such as pharmaceuticals are governed. In modern liberal democracies, governance (a term whose Greek root implies control) depends not only on law and regulation but also on successfully engaging a wide range of interests within society—industry, professionals, and the public—as responsible and accountable. With the emergence of the internet, consumers' access to information and opportunities to purchase goods online may destabilise the established processes regulating prescription drugs.
Technology, governance, and globalisation
For democratic societies, the challenge of governance is to balance and reconcile the differing interests of the state and of individuals in an effort to sustain the continuity, security, and cultural integrity of the state and the liberty and rights of individuals.1 Governance systems can be established in the absence of legal or political authority and often depend on voluntary and consensual processes. A good example is the governance of professions, such as the medical profession, which have applied self regulation and codes of conduct alongside legal frameworks.

A hundred years ago, local pharmacies had no competition from the internet, and governance was more straightforward
Credit: MEPL
Scientific and technological developments such as nuclear power, genetic engineering, food safety, and pharmaceutical innovation all demand regulation for reasons of public health, safety, and security.2–4 These developments require policy makers and professionals to balance a paternalistic responsibility for others against individual freedoms and rights and the commercial interests of industry. New technologies gradually acquire regulatory frameworks as policy makers assess and weigh different interests among innovators, professionals, consumers, and ethicists. For drugs, national governments …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
ESR adaptation for age - A forgotten pearl!
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012